A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma

Only few studies have been evaluated the clinical characteristics and prognosis of hepatocellular carcinoma (HCC) in young patients. The purpose of this study is to identify prognostic factors and develop an efficient and practical nomogram to predict cancer-specific survival (CSS) in young patients...

Full description

Saved in:
Bibliographic Details
Published inTranslational cancer research Vol. 10; no. 4; pp. 1773 - 1786
Main Authors Li, Xingchen, Bi, Xinyu, Zhao, Jianjun, Li, Zhiyu, Zhou, Jianguo, Huang, Zhen, Zhang, Yefan, Zhao, Hong, Cai, Jianqiang
Format Journal Article
LanguageEnglish
Published China AME Publishing Company 01.04.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Only few studies have been evaluated the clinical characteristics and prognosis of hepatocellular carcinoma (HCC) in young patients. The purpose of this study is to identify prognostic factors and develop an efficient and practical nomogram to predict cancer-specific survival (CSS) in young patients with HCC. Four hundred and forty-one young patients with HCC who had undergone surgery from 2004-2015 were selected from the Surveillance, Epidemiology, and End Results (SEER) database. The competing risk model, Lasso and Cox regression were used to screen prognostic factors for CSS, and a prognostic nomogram was established using these factors. Thirty-nine young patients with HCC from the National Cancer Center, Cancer Hospital, Chinese Academy of Medical Science were used to validate our model. To further evaluate the predictive performance of our model, the concordance index was calculated and the calibration curves were drawn. The clinical usefulness was evaluated by decision curve analysis (DCA). Finally, all patients were grouped by our nomogram. The survival of different risk groups was analyzed using the Kaplan-Meier method, and the differences among survival curves were compared by the log-rank test. The median survival times of the SEER training group and the external National Cancer Center validation group were 41 and 52 months, respectively. Histological grade, tumor size, Alpha-fetoprotein (AFP), T stage, and M stage were selected as independent factors for CSS, and a prognostic nomogram was established. The concordance indices of the training and external validation groups were 0.76 (95% CI, 0.72 to 0.80) and 0.92 (SE=0.085), respectively. The calibration plots showed good agreement. DCA revealed that our nomogram resulted in a better clinical net benefit than the AJCC 7th edition and Barcelona Clinic Liver Cancer staging systems. Patients were divided into two risk groups according to the cut-off value of 125 of the total points from our nomogram. Kaplan-Meier plots for CSS were performed using the log-rank test, the P-value of which was <0.001. The practical nomogram resulted in a more-accurate prognostic prediction for young HCC patients after curative liver resection.
AbstractList Only few studies have been evaluated the clinical characteristics and prognosis of hepatocellular carcinoma (HCC) in young patients. The purpose of this study is to identify prognostic factors and develop an efficient and practical nomogram to predict cancer-specific survival (CSS) in young patients with HCC. Four hundred and forty-one young patients with HCC who had undergone surgery from 2004-2015 were selected from the Surveillance, Epidemiology, and End Results (SEER) database. The competing risk model, Lasso and Cox regression were used to screen prognostic factors for CSS, and a prognostic nomogram was established using these factors. Thirty-nine young patients with HCC from the National Cancer Center, Cancer Hospital, Chinese Academy of Medical Science were used to validate our model. To further evaluate the predictive performance of our model, the concordance index was calculated and the calibration curves were drawn. The clinical usefulness was evaluated by decision curve analysis (DCA). Finally, all patients were grouped by our nomogram. The survival of different risk groups was analyzed using the Kaplan-Meier method, and the differences among survival curves were compared by the log-rank test. The median survival times of the SEER training group and the external National Cancer Center validation group were 41 and 52 months, respectively. Histological grade, tumor size, Alpha-fetoprotein (AFP), T stage, and M stage were selected as independent factors for CSS, and a prognostic nomogram was established. The concordance indices of the training and external validation groups were 0.76 (95% CI, 0.72 to 0.80) and 0.92 (SE=0.085), respectively. The calibration plots showed good agreement. DCA revealed that our nomogram resulted in a better clinical net benefit than the AJCC 7th edition and Barcelona Clinic Liver Cancer staging systems. Patients were divided into two risk groups according to the cut-off value of 125 of the total points from our nomogram. Kaplan-Meier plots for CSS were performed using the log-rank test, the P-value of which was <0.001. The practical nomogram resulted in a more-accurate prognostic prediction for young HCC patients after curative liver resection.
BACKGROUNDOnly few studies have been evaluated the clinical characteristics and prognosis of hepatocellular carcinoma (HCC) in young patients. The purpose of this study is to identify prognostic factors and develop an efficient and practical nomogram to predict cancer-specific survival (CSS) in young patients with HCC. METHODSFour hundred and forty-one young patients with HCC who had undergone surgery from 2004-2015 were selected from the Surveillance, Epidemiology, and End Results (SEER) database. The competing risk model, Lasso and Cox regression were used to screen prognostic factors for CSS, and a prognostic nomogram was established using these factors. Thirty-nine young patients with HCC from the National Cancer Center, Cancer Hospital, Chinese Academy of Medical Science were used to validate our model. To further evaluate the predictive performance of our model, the concordance index was calculated and the calibration curves were drawn. The clinical usefulness was evaluated by decision curve analysis (DCA). Finally, all patients were grouped by our nomogram. The survival of different risk groups was analyzed using the Kaplan-Meier method, and the differences among survival curves were compared by the log-rank test. RESULTSThe median survival times of the SEER training group and the external National Cancer Center validation group were 41 and 52 months, respectively. Histological grade, tumor size, Alpha-fetoprotein (AFP), T stage, and M stage were selected as independent factors for CSS, and a prognostic nomogram was established. The concordance indices of the training and external validation groups were 0.76 (95% CI, 0.72 to 0.80) and 0.92 (SE=0.085), respectively. The calibration plots showed good agreement. DCA revealed that our nomogram resulted in a better clinical net benefit than the AJCC 7th edition and Barcelona Clinic Liver Cancer staging systems. Patients were divided into two risk groups according to the cut-off value of 125 of the total points from our nomogram. Kaplan-Meier plots for CSS were performed using the log-rank test, the P-value of which was <0.001. CONCLUSIONSThe practical nomogram resulted in a more-accurate prognostic prediction for young HCC patients after curative liver resection.
Author Zhang, Yefan
Li, Xingchen
Bi, Xinyu
Li, Zhiyu
Huang, Zhen
Cai, Jianqiang
Zhao, Jianjun
Zhou, Jianguo
Zhao, Hong
Author_xml – sequence: 1
  givenname: Xingchen
  surname: Li
  fullname: Li, Xingchen
  organization: Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
– sequence: 2
  givenname: Xinyu
  surname: Bi
  fullname: Bi, Xinyu
  organization: Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
– sequence: 3
  givenname: Jianjun
  surname: Zhao
  fullname: Zhao, Jianjun
  organization: Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
– sequence: 4
  givenname: Zhiyu
  surname: Li
  fullname: Li, Zhiyu
  organization: Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
– sequence: 5
  givenname: Jianguo
  surname: Zhou
  fullname: Zhou, Jianguo
  organization: Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
– sequence: 6
  givenname: Zhen
  surname: Huang
  fullname: Huang, Zhen
  organization: Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
– sequence: 7
  givenname: Yefan
  surname: Zhang
  fullname: Zhang, Yefan
  organization: Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
– sequence: 8
  givenname: Hong
  surname: Zhao
  fullname: Zhao, Hong
  organization: Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
– sequence: 9
  givenname: Jianqiang
  surname: Cai
  fullname: Cai, Jianqiang
  organization: Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35116501$$D View this record in MEDLINE/PubMed
BookMark eNpVkc1r3DAQxUXZ0t183HouOvYQNyPJluRLIYQmKQRyaSCnCFmWvSq2tZHkhv3vo82mS3KaGebx5g2_I7SY_GQR-krgByXAxHkyoaBQsJKQT2hFKakLLoEtXntZcMEflug0xr8AQAmRJfAvaMkqQngFZIUeL_DkR98HPeLk8SbY1pmUq-8nH13Euks24DiH3oYt7nzAWz9PPd7o5OyUIn52aY3XNs_e2GGYBx2w0cG47KtP0OdOD9GevtVjdH_168_lTXF7d_378uK2MEyWqRCma7gQra1qaZuqBd41RFei4o1tBAhNhaV1qXNkptuuZJIQBsaQ2oBmpmHH6OfedzM3o21NThb0oDbBjTpslddOfdxMbq16_09JUUtJeTb4_mYQ_NNsY1Kji7t_9GT9HBXllANIUlZZeraXmuBjDLY7nCGgXqmoTEVRUDsqWf7tfbSD-D8D9gLMEo0K
CitedBy_id crossref_primary_10_3389_fimmu_2022_914977
crossref_primary_10_1016_j_ejso_2023_06_018
crossref_primary_10_1002_cam4_6003
ContentType Journal Article
Copyright 2021 Translational Cancer Research. All rights reserved.
2021 Translational Cancer Research. All rights reserved. 2021 Translational Cancer Research.
Copyright_xml – notice: 2021 Translational Cancer Research. All rights reserved.
– notice: 2021 Translational Cancer Research. All rights reserved. 2021 Translational Cancer Research.
DBID NPM
AAYXX
CITATION
7X8
5PM
DOI 10.21037/tcr-20-3411
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2219-6803
EndPage 1786
ExternalDocumentID 10_21037_tcr_20_3411
35116501
Genre Journal Article
GrantInformation_xml – fundername: the National Capital Health Research and Development of Special
  grantid: No. 2018-1-4021
– fundername: the National Science and Technology Major Project
  grantid: No. 2018ZX10723204
GroupedDBID 53G
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
NPM
OK1
PGMZT
RPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c384t-7cfb677de598eb5d06fb1a5756beb707a27e294a5013adf4381130cc19c0a3cb3
IEDL.DBID RPM
ISSN 2218-676X
IngestDate Tue Sep 17 21:18:04 EDT 2024
Fri Aug 16 11:49:47 EDT 2024
Fri Aug 23 03:20:38 EDT 2024
Sat Sep 28 08:20:36 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 4
Keywords prediction model
nomogram
young patients
prognosis
Hepatocellular carcinoma (HCC)
Language English
License 2021 Translational Cancer Research. All rights reserved.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c384t-7cfb677de598eb5d06fb1a5756beb707a27e294a5013adf4381130cc19c0a3cb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Contributions: (I) Conception and design: J Cai, H Zhao; (II) Administrative support: J Cai, H Zhao; (III) Provision of study materials of patients: X Bi, J Zhao, Z Li; (IV) Collection and assembly of data: J Zhou, Z Huang, Y Zhang; (V) Data analysis and interpretation: X Li; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798826/
PMID 35116501
PQID 2626008145
PQPubID 23479
PageCount 14
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8798826
proquest_miscellaneous_2626008145
crossref_primary_10_21037_tcr_20_3411
pubmed_primary_35116501
PublicationCentury 2000
PublicationDate 2021-Apr
2021-4-00
20210401
PublicationDateYYYYMMDD 2021-04-01
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-Apr
PublicationDecade 2020
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Translational cancer research
PublicationTitleAlternate Transl Cancer Res
PublicationYear 2021
Publisher AME Publishing Company
Publisher_xml – name: AME Publishing Company
SSID ssj0002118406
Score 2.255178
Snippet Only few studies have been evaluated the clinical characteristics and prognosis of hepatocellular carcinoma (HCC) in young patients. The purpose of this study...
BACKGROUNDOnly few studies have been evaluated the clinical characteristics and prognosis of hepatocellular carcinoma (HCC) in young patients. The purpose of...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1773
SubjectTerms Original
Title A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma
URI https://www.ncbi.nlm.nih.gov/pubmed/35116501
https://search.proquest.com/docview/2626008145
https://pubmed.ncbi.nlm.nih.gov/PMC8798826
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF7anryI4qu-WEGPaZPNY5NjKZYiKB4s9GTYV2jBJqVJD_57ZzZJafXmOcmQnUx2vm_32xlCHl1PJFJJ19ECl25CkTjSywJHKS4MDzRjxgpk36LpLHiZh_MOCduzMFa0r-RykH-tBvlyYbWV65Uatjqx4fvrOMYiWywadkkXAnSPouP0C4wGSIttKgfpy4l4NK8F78wW84H5zcFDw4GHTWJwGw0wineYlf5Azd-Kyb0UNDkhxw12pKP6HU9Jx-Rn5HNE82JlRVa0Kuh6gzsvFUXdVV6Uy5LaLuC0rI8_U8Co9Bv_cNpUVC0pLsXSBaSlqsBlfNSlUoUthsCuOCezyfPHeOo0TRMc5cdB5XCVyYhzbcIkNjLUbpRJTwAoi6SR3OWCccOSQMCgfaEzrPAFaUwpL1Gu8JX0L0gvL3JzRajWiXCBwcaSGaSBSRYazwDFYtoVYLlPnlqnpeu6NkYKnML6OQU_p8xN0c998tB6NIXgxaGI3BTbMmVIpwCUBGGfXNYe3llqP02f8APf727AwtiHVyBebIHsJj6u__3kDTliqF2xCp1b0qs2W3MH4KOS9zbYfgAovNxq
link.rule.ids 230,315,730,783,787,888,27938,27939,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9owEB2x28PupR_qdks_Xal7DDgmiclxhYpoC6gHqDhtZDuOQFsSRMKh_fWdcQiC7al7TmLFebFnnv38BuAz91WsjeZeqmjpJlSxp_0s8IyRysogFcI6gew0Gs2Db4tw0YKwOQvjRPtGrzr5r3UnXy2dtnKzNt1GJ9b9MRn0yWRLRN0zeILjlUdHJJ0mYOQ0SFtcWTkMYF4ko0UteRfOzgdnOI-ODQc-lYmhjTTMUvzTuPRPsvlQM3kUhIbP4Gfz-rX25L6zq3TH_Hng7Pjf_XsOT_dpKbutL7-Als1fwt0ty4u102-xqmCbLW3qVIwkXXlRrkrmCoyzsj5ZzTD9Zb9p8mB7s9aS0SovW2LEqwraISDJKzNUvQjbVVcwH36ZDUbevh6DZ3r9oPKkyXQkZWrDuG91mPIo077CfC_SVksulZBWxIHCr9lTaUbmYRghjfFjw1XP6N4rOM-L3L4Glqax4kiO-1pYYphxFlrfInsTKVfYchtuGjSSTW27kSBdcQAmCGAieEIAtuFTA1WC44K6onJb7MpEEFPDfCcI23BdQ3doqcG8DfIE1MMN5Ll9egWhct7be2jePPrJj3Axmk3Gyfjr9PtbuBQkkXFCoHdwXm139j3mOJX-4P7ovwIt_nI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswEB20KVD0kqboEqcbC7RH2RQtidLRcGOkm-FDDRg9VOAmxEgsGZF8SL6-M5QV2O4tZ1EEqCdy5pGPbwA-81Bl2mgeWEVbN7HKAh0WUWCMVE5GVgjnBbLT5GIefV_Ei51SX160b_SyX16v-uXy0msr1ysz6HRig9mvcUomWyIZrG0xeAxPcM7ydIeo0yKMvAapiy8th0EsSGSyaGXvwlv64CoX0NXhKKRSMXSYhplKuB-b_ks4D3WTO4Fo8hz-dENo9SdX_U2j--buwN3xQWM8geNtespGbZMX8MiVL-HviJXVyuu4WFOx9Q0d7jSMpF1lVS9r5guNs7q9Yc0wDWa3tIiwrWlrzWi3l11i5GsqOikg6SszVMUI-1WvYD45_z2-CLZ1GQIzTKMmkKbQiZTWxVnqdGx5UuhQYd6XaKcll0pIJ7JI4RcdKluQiRhGSmPCzHA1NHr4Go7KqnSnwKzNFEeSnGrhiGlmRexChyxOWK6w5x586RDJ1639Ro60xYOYI4i54DmB2INPHVw5zg8aiipdtalzQYwN854o7sGbFr77njrceyD3gL1vQN7b-08QLu_BvYXn7MFvfoSns6-T_Oe36Y-38EyQUsbrgd7BUXOzce8x1Wn0B_9T_wPvygEB
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+nomogram+to+predict+prognosis+after+surgery+for+young+patients+with+hepatocellular+carcinoma&rft.jtitle=Translational+cancer+research&rft.au=Li%2C+Xingchen&rft.au=Bi%2C+Xinyu&rft.au=Zhao%2C+Jianjun&rft.au=Li%2C+Zhiyu&rft.date=2021-04-01&rft.issn=2218-676X&rft.eissn=2219-6803&rft.volume=10&rft.issue=4&rft.spage=1773&rft.epage=1786&rft_id=info:doi/10.21037%2Ftcr-20-3411&rft.externalDBID=n%2Fa&rft.externalDocID=10_21037_tcr_20_3411
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2218-676X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2218-676X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2218-676X&client=summon